2022
DOI: 10.1093/bioinformatics/btac301
|View full text |Cite
|
Sign up to set email alerts
|

GEInfo: an R package for gene–environment interaction analysis incorporating prior information

Abstract: Summary Gene-environment (G-E) interactions have important implications for many complex diseases. With higher dimensionality and weaker signals, G-E interaction analysis is more challenged than the analysis of main G (and E) effects. The accumulation of published literature makes it possible to borrow strength from prior information and improve analysis. In a recent study, a “quasi-likelihood + penalization” approach was developed to effectively incorporate prior information. Here, we first … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…The propensity-score integrated power prior [17] and the composite likelihood method [18] are implemented in the R package psrwe [19]. The program is easy to use, including functions to implement each step of the process, starting with one function to estimate the propensity scores efalse(Xfalse), a function to create the stratification, and finally two functions to implement either the PS-integrated power prior or the composite likelihood, as desired.…”
Section: Real-world Evidence In Bayesian Clinical Trial Designsmentioning
confidence: 99%
“…The propensity-score integrated power prior [17] and the composite likelihood method [18] are implemented in the R package psrwe [19]. The program is easy to use, including functions to implement each step of the process, starting with one function to estimate the propensity scores efalse(Xfalse), a function to create the stratification, and finally two functions to implement either the PS-integrated power prior or the composite likelihood, as desired.…”
Section: Real-world Evidence In Bayesian Clinical Trial Designsmentioning
confidence: 99%